We are monitoring the impact of COVID-19 on Ovarian Cancer Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1391
Share on
Share on

Global Ovarian Cancer Therapeutics Market Size, Share, Trends & Growth Analysis Report – Segmented By Stage of Cancer, Cancer Type, Diagnosis, Type of Treatment & Region – Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 1391
Pages: 181

Ovarian Cancer Therapeutics Market Size (2020 to 2025)

The size of the Global Ovarian Cancer Therapeutics Market is predicted to register a CAGR of 10.1% from 2020 to 2025.

The formation of mutational cells or tissues in female reproductive organs called ovaries leads to ovarian cancer. Cancer remains undetected until the mutation spread to the stomach and pelvis, which is a very advanced stage of ovarian cancer, which is fatal. A substantial percentage of women are dying due to ovarian cancer across the world. Ovarian cancer shows any pious symptoms in the affected women, but they might experience pain in the abdomen, fatigue, indigestion, bloating, and nausea.

Key Market Drivers

The significant factors that are significantly boosting the growth of the global ovarian cancer therapeutics market are the rise in aged women's accounts and the increased prevalence of ovarian cancer across the world. The increasing economies of the countries in the developed and developing regions are leading to the expansion of healthcare. They are contributing to the growth of the global ovarian cancer therapeutics market.

Additionally, the increasing adoption rate of combination therapies for the treatment is another significant factor that catalyzes the growth of this market. Increased funding from governments and private organizations to research and develop effective treatment techniques and advanced therapeutics for treating ovarian cancer is boosting the worldwide ovarian cancer therapeutics market.

Potential Opportunities

The healthcare industry is anticipated to witness the rise in the number of medical professionals at a significant rate, which is supposed to create lucrative growth opportunities for key market players in the global ovarian cancer therapeutics market over the forecast period world. Increasing demand for home care services and nurses due to an increased percentage of the aged population is likely to offer several growth opportunities for the market stakeholders.

Rising investments and funding from governments in the developed nations for the research and development activities to battles the ovarian cancer is suspected of creating growth opportunities for the key players functioning in the world's ovarian cancer therapeutics market.

Major Challenges

The unavailability of adequate technology for detecting ovarian cancer in early stages is the major challenge limiting the growth of the global ovarian cancer therapeutics business. Lack of skilled professionals is challenging the key players for the growth of the market. Also, the lack of funding for research and development activities is challenging the growth of the ovarian cancer therapeutics industry.

Impact of COVID-19 pandemic on the global ovarian cancer therapeutics market 

The COVID-19 pandemic has negatively affected many countries across the globe. Several measures introduced to deal with the pandemic, such as lockdowns, reduction in trade activities, and shutdown of multiple factories and workplaces in several countries, could save lives; however, these measures have wide-ranging economic effects inducing economic contagion. Along with the risk of a slowdown of global growth, the results of COVID-19 are adversely affecting various economic sectors in economies across the globe.

Key manufacturing segments have halted operations across the globe in response to the lockdown regulations issued by governments of various countries and discontinuing public transport services.

Amid the COVID-19 pandemic, the Ovarian Cancer Therapeutics Market is witnessing a significant change in operations.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Stage of Cancer, Diagnosis, Type of Treatment, Type of Cancer and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global ovarian cancer therapeutics market has been segmented and sub-segmented based on the stage of cancer, diagnosis, type of treatment, type of cancer, and region.

 Ovarian Cancer Therapeutics Market - By Stage of Cancer:

  • Stage I
    • Stage IA
    • Stage IB
    • Stage IC
  • Stage II
    • Stage IIA
    • Stage IIB
    • Stage IIC
  • Stage III
    • Stage IIIA
    • Stage IIIB
    • Stage IIIC
  • Stage IV

Ovarian Cancer Therapeutics Market - By Cancer Type:

  • Primary Peritoneal Carcinoma
  • Ovarian Stromal Tumors
  • Ovarian Germ Cell Tumors
  • Epithelial Ovarian Tumors

Based on the cancer type, the epithelial ovarian cancer segment is predicted to hold leading shares in the global market during the forecast period. The rising population and growing awareness over the availability of treatment procedures bolstered the demand for this market. Increasing incidences of ovarian cancer patients propel the growth rate of the ovarian low malignant potential tumor segment.

Ovarian Cancer Therapeutics Market - By Diagnosis:

  • Physical Examination
  • Blood Tests
  • Ultrasound
  • PET
  • CT Scan
  • MRI
  • Human Chorionic Gonadotropin Test
  • Biopsy

Ovarian Cancer Therapeutics Market - By Type of Treatment:

  • Chemotherapy
  • Radiation Therapy
  • Hormonal Therapy
  • Surgery
  • Immunotherapy
  • Targeted Therapy

Based on the type of treatment, Immunotherapy is dominating the market. It is presumed to grow at a high pace during the forecast period due to the continually increasing adoption rate of immunotherapy treatments and the expansion of healthcare, leading to the rise in the number of patients diagnosed with ovarian cancer undergoing immunotherapy.

The targeted therapy market is continuously increasing at a high rate of CAGR. It is likely to continue the trend during the forecast period due to the increasing popularity of targeted therapies and the rising prevalence of women affected by ovarian cancer.  

Ovarian Cancer Therapeutics Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

North America is dominating the Global Ovarian Cancer Therapeutics Market. It is assumed to continue the trend during the outlook period due to the increasing pervasiveness of ovarian cancer and the geriatric population's growing account. The United States controls the highest share in the ovarian cancer diagnostics and therapeutics market and has added significantly. Ovarian cancer is the ninth most common cancer and the fifth leading cause of cancer death among women in the United States. Furthermore, most of the top global ovarian cancer diagnostics players are based in the United States. It tends to be a significant advantage for the region, which is expected to drive the market.

Asia-Pacific demand is contributing a significant share of revenues to the market. It is likely to witness growth at high CAGR during the projection period due to the increasing prevalence of the aged population and the growing economies of countries such as China and India.

NOTABLE COMPANIES IN THE MARKET

Companies leading the global ovarian cancer therapeutics market profiled in the report are Aetera Zenteris Inc., Eli Lilly and Company, Roche, Amgen, Janssen Pharmaceuticals, Inc., Bristol Myers Squibb Company, Novogen, Inc., GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, and Genentech Inc.

KEY MARKET RECENT HAPPENINGS:

GlaxoSmithKline plc has developed a novel drug for women diagnosed with advanced ovarian cancer. The company has applied for the approval of a drug called zejula to the FDA in February 2020; the FDA aims for the efficient reviewing process to make it available for the patients.

In the recent studies, the researchers have identified a new drug fragment; as per the reports published by the research team, the pieces can help analyze the function of cancer protein leading to the development of drugs in the future.

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 Epidemology             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 Stage Of Cancer        

                                5.1.1 Stage I

                               

                               

                               

                                5.1.2 Stage II

                               

                               

                               

                                5.1.3 Stage III

                               

                               

                               

                                5.1.4 Stage IV

                                5.1.5 Y-o-Y Growth Analysis, By Stage Of Cancer

                                5.1.6 Market Attractiveness Analysis, By Stage Of Cancer

                                5.1.7 Market Share Analysis, By Stage Of Cancer

                5.2 Type              

                                5.2.1 Introduction

                                5.2.2 Primary Peritoneal Carcinoma

                                5.2.3 Ovarian Stromal Tumors

                                5.2.4 Ovarian Germ Cell Tumors

                                5.2.5 Epithelial Ovarian Tumors

                                5.2.6 Y-o-Y Growth Analysis, By Type

                                5.2.7 Market Attractiveness Analysis, By Type

                                5.2.8 Market Share Analysis, By Type

                5.3 Diagnosis     

                                5.3.1 Introduction

                                5.3.2 Physical Examination

                                5.3.3 Blood Tests

                                5.3.4 Ultrasound

                                5.3.5 PET

                                5.3.6 CT Scan

                                5.3.7 MRI

                                5.3.8 Human Chorionic Gonadotropin Test

                                5.3.9 Biopsy

                                5.3.10 Y-o-Y Growth Analysis, By Diagnosis

                                5.3.11 Market Attractiveness Analysis, By Diagnosis

                                5.3.12 Market Share Analysis, By Diagnosis

                5.4 Treatment  

                                5.4.1 Introduction

                                5.4.2 Chemotherapy

                                5.4.3 Radiation Therapy

                                5.4.4 Hormonal Therapy

                                5.4.5 Surgery

                                5.4.6 Immunotherapy

                                5.4.7 Targeted Therapy

                                5.4.8 Y-o-Y Growth Analysis, By Treatment

                                5.4.9 Market Attractiveness Analysis, By Treatment

                                5.4.10 Market Share Analysis, By Treatment

6. Geographical Analysis                              

                6.1 Introduction              

                                6.1.1 Regional Trends

                                6.1.2 Impact Analysis

                                6.1.3 Y-o-Y Growth Analysis

                               

                               

                               

                               

                               

                                6.1.4 Market Attractiveness Analysis

                               

                               

                               

                               

                               

                                6.1.5 Market Share Analysis

                               

                               

                               

                               

                               

                6.2 North America          

                                6.1.1 Introduction

                                6.1.2 United States

                                6.1.3 Canada 

                6.3 Europe         

                                6.2.1 Introduction

                                6.2.2 U.K

                                6.2.3 Spain

                                6.2.4 Germany

                                6.2.5 Italy 

                                6.2.6 France

                6.4 Asia-Pacific 

                                6.3.1 Introduction

                                6.3.2 China 

                                6.3.3 India 

                                6.3.4 Japan 

                                6.3.5 Australia

                                6.3.6 South Korea

                6.5 Latin America            

                                6.4.1 Introduction

                                6.4.2 Brazil

                                6.4.3 Argentina

                                6.4.4 Mexico

                                6.4.5 Rest of Latin America

                6.6 Middle East & Africa

                                6.5.1 Introduction

                                6.5.2 Middle-East

                                6.5.3 Africa

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Aetera Zenteris Inc.

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Financial analysis

                                8.1.4 Recent Developments

                                8.1.5 SWOT analysis

                                8.1.6 Analyst View

                8.2 Eli Lilly and Company             

                8.3 Roche           

                8.4 Amgen         

                8.5 Janssen Pharmaceuticals, Inc.             

                8.6 Bristol Myers Squibb Company          

                8.7 Novogen, Inc.            

                8.8 GlaxoSmithKline      

                8.9 Boehringer Ingelheim            

                8.10 AstraZeneca            

                8.11 Genentech Inc.       

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Market Outlook and Investment Opportunities                           

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Global, Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Ovarian Cancer Therapeutics Market, By Region, From 2020 to 2025
  2. Global Ovarian Cancer Therapeutics Market, By Stage Of Cancer, From 2020 to 2025
  3. Global Stage I Market, By Region, From 2020 to 2025
  4. Global Stage II Market, By Region, From 2020 to 2025
  5. Global Stage III Market, By Region, From 2020 to 2025
  6. Global Stage IV Market, By Region, From 2020 to 2025
  7. Global Ovarian Cancer Therapeutics Market, By Cancer Type, From 2020 to 2025
  8. Global Primary Peritoneal Carcinoma Market, By Region, From 2020 to 2025
  9. Global Ovarian Stromal Tumors Market, By Region, From 2020 to 2025
  10. Global Ovarian Germ Cell Tumors Market, By Region, From 2020 to 2025
  11. Global Epithelial Ovarian Tumors Market, By Region, From 2020 to 2025
  12. Global Ovarian Cancer Therapeutics Market, By Diagnosis, From 2020 to 2025
  13. Global Physical Examination Market, By Region, From 2020 to 2025
  14. Global Blood Tests Market, By Region, From 2020 to 2025
  15. Global Ultrasound Market, By Region, From 2020 to 2025
  16. Global PET Market, By Region, From 2020 to 2025
  17. Global CT Scan Market, By Region, From 2020 to 2025
  18. Global MRI Market, By Region, From 2020 to 2025
  19. Global Human Chorionic Gonadotropin Test Market, By Region, From 2020 to 2025
  20. Global Biopsy Market, By Region, From 2020 to 2025
  21. Global Ovarian Cancer Therapeutics Market, By Type Of Treatment, From 2020 to 2025
  22. Global Chemotherapy Market, By Region, From 2020 to 2025
  23. Global Radiation Therapy Market, By Region, From 2020 to 2025
  24. Global Hormonal Therapy Market, By Region, From 2020 to 2025
  25. Global Surgery Market, By Region, From 2020 to 2025
  26. Global Immunotherapy Market, By Region, From 2020 to 2025
  27. Global Targeted Therapy Market, By Region, From 2020 to 2025
  28. Global Blood Glucose Monitoring Market, By Stage I, From 2020 to 2025
  29. Global Stage IA Market, By Region, From 2020 to 2025
  30. Global Stage IB Market, By Region, From 2020 to 2025
  31. Global Stage IC Market, By Region, From 2020 to 2025
  32. Global Blood Glucose Monitoring Market, By Stage II, From 2020 to 2025
  33. Global Stage IIA Market, By Region, From 2020 to 2025
  34. Global Stage IIB Market, By Region, From 2020 to 2025
  35. Global Stage IIC Market, By Region, From 2020 to 2025
  36. Global Blood Glucose Monitoring Market, By Stage III, From 2020 to 2025
  37. Global Stage IIIA Market, By Region, From 2020 to 2025
  38. Global Stage IIIB Market, By Region, From 2020 to 2025
  39. Global Stage IIIC Market, By Region, From 2020 to 2025

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample